Intermittent schedules of the oral RAF–MEK inhibitor...

  • Main
  • 2020 / 10
  • Intermittent schedules of the oral RAF–MEK inhibitor...
The Lancet Oncology 2020 / 10

Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study

Guo, Christina, Chénard-Poirier, Maxime, Roda, Desamparados, de Miguel, Maria, Harris, Samuel J, Candilejo, Irene Moreno, Sriskandarajah, Priya, Xu, Wen, Scaranti, Mariana, Constantinidou, Anastasia,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30464-2
Date:
October, 2020
File:
PDF, 1.23 MB
2020
Conversion to is in progress
Conversion to is failed